Iodoquinazoline-derived VEGFR-2 and EGFR
ADMET
Anticancer
Iodoquinazoline
Tyrosine kinase
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
25 Dec 2023
25 Dec 2023
Historique:
received:
29
09
2023
revised:
20
11
2023
accepted:
23
12
2023
medline:
28
12
2023
pubmed:
28
12
2023
entrez:
27
12
2023
Statut:
aheadofprint
Résumé
Herein, we report the synthesis of a series of new fourteen iodoquinazoline derivatives 7a-c to 13a-e and their evaluation as potential anticancer agents via dual targeting of EGFR
Identifiants
pubmed: 38150938
pii: S0045-2068(23)00723-X
doi: 10.1016/j.bioorg.2023.107062
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107062Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.